These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 33645607)

  • 1. Tacrine-sugar mimetic conjugates as enhanced cholinesterase inhibitors.
    Oliveira de Santana QL; Santos Evangelista TC; Imhof P; Ferreira SB; Fernández-Bolaños JG; Sydnes MO; Lopéz Ó; Lindbäck E
    Org Biomol Chem; 2021 Mar; 19(10):2322-2337. PubMed ID: 33645607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, kinetic studies and molecular modeling of novel tacrine dimers as cholinesterase inhibitors.
    de Aquino RA; Modolo LV; Alves RB; de Fátima Â
    Org Biomol Chem; 2013 Dec; 11(48):8395-409. PubMed ID: 24186541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and pharmacological evaluation of huprine-tacrine heterodimers: subnanomolar dual binding site acetylcholinesterase inhibitors.
    Camps P; Formosa X; Muñoz-Torrero D; Petrignet J; Badia A; Clos MV
    J Med Chem; 2005 Mar; 48(6):1701-4. PubMed ID: 15771413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular-docking-guided design and synthesis of new IAA-tacrine hybrids as multifunctional AChE/BChE inhibitors.
    Cheng ZQ; Zhu KK; Zhang J; Song JL; Muehlmann LA; Jiang CS; Liu CL; Zhang H
    Bioorg Chem; 2019 Mar; 83():277-288. PubMed ID: 30391700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conjugates of Tacrine and Its Cyclic Homologues with p-Toluenesulfonamide as Novel Acetylcholinesterase and Butyrylcholinesterase Inhibitors.
    Makhaeva GF; Kovaleva NV; Lushchekina SV; Rudakova EV; Boltneva NP; Proshin AN; Lednev BV; Serkov IV; Bachurin SO
    Dokl Biochem Biophys; 2018 Nov; 483(1):369-373. PubMed ID: 30607741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NO-donating tacrine derivatives as potential butyrylcholinesterase inhibitors with vasorelaxation activity.
    Chen Y; Sun J; Huang Z; Liao H; Peng S; Lehmann J; Zhang Y
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3162-5. PubMed ID: 23639542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel heterobivalent tacrine derivatives as cholinesterase inhibitors with notable selectivity toward butyrylcholinesterase.
    Elsinghorst PW; Tanarro CM; Gütschow M
    J Med Chem; 2006 Dec; 49(25):7540-4. PubMed ID: 17149883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, biological evaluation and molecular modeling of aloe-emodin derivatives as new acetylcholinesterase inhibitors.
    Shi DH; Huang W; Li C; Wang LT; Wang SF
    Bioorg Med Chem; 2013 Mar; 21(5):1064-73. PubMed ID: 23380475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of novel tacrine derivatives and tacrine-coumarin hybrids as cholinesterase inhibitors.
    Hamulakova S; Janovec L; Hrabinova M; Spilovska K; Korabecny J; Kristian P; Kuca K; Imrich J
    J Med Chem; 2014 Aug; 57(16):7073-84. PubMed ID: 25089370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel series of tacrine-tianeptine hybrids: Synthesis, cholinesterase inhibitory activity, S100B secretion and a molecular modeling approach.
    Ceschi MA; da Costa JS; Lopes JPB; Câmara VS; Campo LF; Borges ACA; Gonçalves CAS; de Souza DF; Konrath EL; Karl ALM; Guedes IA; Dardenne LE
    Eur J Med Chem; 2016 Oct; 121():758-772. PubMed ID: 27392529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of tacrine clusters as positively cooperative systems for the inhibition of acetylcholinesterase.
    Evangelista TCS; López Ó; Ferreira SB; Fernández-Bolaños JG; Sydnes MO; Lindbäck E
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1659-1664. PubMed ID: 34294013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific targeting of acetylcholinesterase and butyrylcholinesterase recognition sites. Rational design of novel, selective, and highly potent cholinesterase inhibitors.
    Savini L; Gaeta A; Fattorusso C; Catalanotti B; Campiani G; Chiasserini L; Pellerano C; Novellino E; McKissic D; Saxena A
    J Med Chem; 2003 Jan; 46(1):1-4. PubMed ID: 12502352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel tacrine-ebselen hybrids with improved cholinesterase inhibitory, hydrogen peroxide and peroxynitrite scavenging activity.
    Mao F; Chen J; Zhou Q; Luo Z; Huang L; Li X
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6737-42. PubMed ID: 24220172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and biological activity of novel tacrine-isatin Schiff base hybrid derivatives.
    Riazimontazer E; Sadeghpour H; Nadri H; Sakhteman A; Tüylü Küçükkılınç T; Miri R; Edraki N
    Bioorg Chem; 2019 Aug; 89():103006. PubMed ID: 31158577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the interactions between coumarin-derivatives and acetylcholinesterase: Examination by NMR and docking simulations.
    Tanoli NU; Tanoli SAK; Ferreira AG; Mehmood M; Gul S; Monteiro JL; Vieira LCC; Venâncio T; Correa AG; Ul-Haq Z
    J Mol Model; 2018 Jul; 24(8):207. PubMed ID: 30008113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tacrine-O-protected phenolics heterodimers as multitarget-directed ligands against Alzheimer's disease: Selective subnanomolar BuChE inhibitors.
    Roldán-Peña JM; Romero-Real V; Hicke J; Maya I; Franconetti A; Lagunes I; Padrón JM; Petralla S; Poeta E; Naldi M; Bartolini M; Monti B; Bolognesi ML; López Ó; Fernández-Bolaños JG
    Eur J Med Chem; 2019 Nov; 181():111550. PubMed ID: 31376562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and structure-activity relationship study of tacrine-based pyrano[2,3-c]pyrazoles targeting AChE/BuChE and 15-LOX.
    Pourabdi L; Khoobi M; Nadri H; Moradi A; Moghadam FH; Emami S; Mojtahedi MM; Haririan I; Forootanfar H; Ameri A; Foroumadi A; Shafiee A
    Eur J Med Chem; 2016 Nov; 123():298-308. PubMed ID: 27484515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conjugates of tacrine and 1,2,4-thiadiazole derivatives as new potential multifunctional agents for Alzheimer's disease treatment: Synthesis, quantum-chemical characterization, molecular docking, and biological evaluation.
    Makhaeva GF; Kovaleva NV; Boltneva NP; Lushchekina SV; Rudakova EV; Stupina TS; Terentiev AA; Serkov IV; Proshin AN; Radchenko EV; Palyulin VA; Bachurin SO; Richardson RJ
    Bioorg Chem; 2020 Jan; 94():103387. PubMed ID: 31735356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterodimeric tacrine-based acetylcholinesterase inhibitors: investigating ligand-peripheral site interactions.
    Carlier PR; Chow ES; Han Y; Liu J; El Yazal J; Pang YP
    J Med Chem; 1999 Oct; 42(20):4225-31. PubMed ID: 10514292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of huperzine A-tacrine hybrids as potent inhibitors of human cholinesterases targeting their midgorge recognition sites.
    Gemma S; Gabellieri E; Huleatt P; Fattorusso C; Borriello M; Catalanotti B; Butini S; De Angelis M; Novellino E; Nacci V; Belinskaya T; Saxena A; Campiani G
    J Med Chem; 2006 Jun; 49(11):3421-5. PubMed ID: 16722663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.